Search
EN

FGF19 human ELISA

Brand: Diagnostics
Enzyme immunoassay for the quantitative determination Human FGF19 in EDTA plasma and cell culture supernatant
SKU: JP27996

Register or Log In in order to request a quote

Register Login

Products specifications
TechnologyELISA
Sizes96 tests
Enzyme immunoassay for the quantitative determination Human FGF19 in EDTA plasma and cell culture supernatant.

INTENDED USE:This assay kit is capable for the quantitative determination Human FGF19 in EDTA plasma and cell culture supernatant. Guideline of dilution for EDTA plasma samples of normal human is around 4-16fold. For research use only, not for use in diagnostic procedures.

GENERAL INFORMATION:FGF19 subfamily composed of FGF19, FGF21 and FGF23 binds the receptors, α/βKlotho and it is characterized as a factor group which has hormonal functions. The novel system consisted of α/βKlotho and FGF19 subfamily regulates integrally metabolism of minerals, lipids, energy and amino acids. This novel regulating system involves important homeostatic mechanism for biological body such as metabolism of bile acid and cholesterol in the liver (FGF19), energy and glycolipids metabolism (FGF21) and phosphate, calcium and vitamin D metabolism in kidney (FGF23) in fasting state. FGF19 is secreted from intestine and transported to liver through bloodstream. It suppresses synthesis of bile acid in liver and regulates the function of liver that preserves sugar as a glycogen. FGF19 binds a receptor consisted of FGFR4 and βKlotho. FGF19 is studied in relation to digestive disorders such as diarrhea and constipation which might be related to FGF19 hormonal abnormality and metabolic disorders such as diabetes. The concentration of FGF19 in blood is measured and reported its involvement with many disease such as polycystic ovary syndrome history, bile acid diarrhea, coronary artery disease, pediatric nonalcoholic fatty liver disease, impaired fasting glucose, quiescent Crohn's colitis, hepatocellular carcinoma, type 2 diabetic patients with metabolic syndrome and anorexia nervosa. This kit can assay Human blood FGF19 density.

KIT CHARACTERISTICS:
- Method: ELISA
- Tests: 96
- Incubation Time / Conditions: overnight, 30 (4°C), 30 min (RT)
- Standard Range: 23.4 - 1,500 pg/ml
- Sensitivity analytical: 7.2 pg/ml
- Final Sample Volume: 100 µl
- Sample Type: plasma, cell culture supernatant
- Sample Pretreatment: dilution
- Isotope / Substrate: TMB 450 nm
- Regulatory Status: RUO